Category Archives: Press Release

Cue Health and BioReference Laboratories Bring Point-of-Care Solutions to the Clinical Setting

Cue Health debuts Cue Clinic™ dashboard to give healthcare providers more choice and control over patient care as part of BioReference’s product offering SAN DIEGO and ELMWOOD PARK, N.J., April 5, 2022 /PRNewswire/ — Cue Health Inc. (“Cue”) (Nasdaq: HLTH), the healthcare technology company behind one of the country’s most accurate COVID-19 tests and BioReference Laboratories, Inc., an OPKO Health company (“BioReference”), today announced […]

9am.health Offers Affordable, Convenient, On-Demand Specimen Collection through BioReference Laboratories

"Providing a digital experience is imperative as healthcare is increasingly shifting to meet patients where they are," Richard Schwabacher, Chief Digital Officer at BioReference Laboratories.

SAN DIEGO, March 10, 2022  — 9am.health, a new virtual diabetes clinic, is proud to announce its collaboration with BioReference Laboratories, Inc., an OPKO Health company, to offer their patients the ability to get blood drawn for diagnostic laboratory tests from the convenience of their own home or workplace, leveraging Scarlet Health®, BioReference’s integrated digital platform. Patients will benefit […]

MVP Health Care Offers On-Demand COVID-19 PCR Testing and Laboratory Collections

First regional health plan to offer innovative digital platform providing safe and affordable diagnostic services Schenectady, NY — December 21, 2021 — MVP Health Care(MVP) today announced a collaboration  with BioReference Laboratories, Inc., an OPKO Health company, to offer MVP members medically necessary COVID-19 testing, bloodwork, and other diagnostic tests in the comfort of their homes. MVP, […]

BioReference Laboratories Announces Readiness for COVID-19 Testing if the Omicron COVID-19 Variant Emerges in The U.S.

ELMWOOD PARK, N.J., November 29, 2021 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), announced COVID-19 testing preparedness for the Omicron Variant. BioReference’s PCR diagnostic tests for SARS-CoV-2 COVID-19 are based on recognizing specific RNA target genes that are common to all coronaviruses. To date, the diagnostic targets have not changed with the novel […]

Richard Schwabacher Named to Modern Healthcare’s Top 25 Emerging Leaders List

ELMWOOD PARK, NJ and Chicago, IL (October 6, 2021) – BioReference Laboratories’ Richard Schwabacher is among Modern Healthcare’s 2021 class of Top 25 Emerging Leaders. Modern Healthcare, the leader in healthcare business news, research and data, annually honors emerging leaders all age 40 or under, who have made significant contributions in the areas of innovation […]

Sports Tech Company, Orreco and Scarlet Health® team up to provide a new solution for Athletes to optimize performance

Los Angeles CA – (Sep 1, 2021) Specialist sports performance and biomarker company Orreco have joined forces with Scarlet Health®, an on-demand diagnostic service by BioReference Laboratories Inc., an OPKO Health company (NASDAQ:OPK), providing a superior, fully integrated digital solution that addresses modern testing needs, to provide a new solution for pre-season athlete physicals and in-season […]

Rite Aid, in Partnership with the U.S. Department of Health and Human Services, BioReference Laboratories and New York State, Announces ‘Back to School’ COVID-19 Testing Program

New York students K-12 will have the opportunity for COVID-19 testing prior to or at the start of the 2021-2022 school year through Rite Aid and BioReference CAMP HILL, Pa. (August 26, 2021) – Rite Aid (NYSE: RAD) and the U.S. Department of Health and Human Services (HHS), together with BioReference Laboratories, Inc., an OPKO Health […]

BioReference Laboratories Acquires U.S. Ariosa Centralized Laboratory Prenatal Testing Business

ELMWOOD PARK, N.J., August 16, 2021 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced the acquisition of the U.S. Ariosa centralized laboratory prenatal testing business from Roche. Ariosa’s non invasive prenatal screening (NIPS) test, the Harmony Prenatal Test, is one of the most widely studied tests utilized in prenatal screening. The test has been performed in […]